Stryker Corp

More

• Midday Glance: Medical Devices companies Friday, 24 May 2013 | 1:18 PM ET

  Allergan rose$. 04 or percent, to $98.00. Baxter International Inc. fell$. 48 or. 7 percent, to $71.67. Boston Scientific Corp. fell$. 02 or. 2 percent, to $9.14.

• Early Glance: Medical Devices companies Thursday, 23 May 2013 | 10:46 AM ET

  Allergan rose$. 29 or. 3 percent, to $98.02. Baxter International Inc. fell$. 58 or. 8 percent, to $71.72. Boston Scientific Corp. fell$. 07 or. 8 percent, to $9.06.

• Midday Glance: Medical Devices companies Wednesday, 22 May 2013 | 1:17 PM ET

  Allergan rose$. 06 or. 1 percent, to $98.60. Baxter International Inc. rose$. 16 or. 2 percent, to $73.20. St. Jude Medical Inc. fell$. 27 or. 6 percent, to $46.51.

• Final Glance: Medical Devices companies Tuesday, 21 May 2013 | 8:50 PM ET

  Allergan rose$. 09 or. 1 percent, to $98.54. Baxter International Inc. rose$. 10 or. 1 percent, to $73.04. Boston Scientific Corp. fell$. 02 or. 2 percent, to $9.23.

• Midday Glance: Medical Devices companies Friday, 17 May 2013 | 1:33 PM ET

  Allergan fell$. 34 or. 3 percent, to $100.08. Baxter International Inc. rose$. 68 or. 9 percent, to $72.53. Boston Scientific Corp. rose$. 04 or. 4 percent, to $9.08.

• Early Glance: Medical Devices companies Friday, 17 May 2013 | 10:25 AM ET

  Allergan fell$. 01 or percent, to $100.41. Baxter International Inc. rose$. 99 or 1.4 percent, to $72.84. Boston Scientific Corp. rose$. 07 or. 8 percent, to $9.11.

• Midday Glance: Medical Devices companies Thursday, 16 May 2013 | 1:29 PM ET

  Allergan fell $1.77 or 1.7 percent, to $101.05. Baxter International Inc. rose$. 82 or 1.2 percent, to $71.37. Boston Scientific Corp. fell$. 06 or. 7 percent, to $9.04.

• Early Glance: Medical Devices companies Thursday, 16 May 2013 | 10:34 AM ET

  Allergan fell $2.36 or 2.3 percent, to $100.46. Baxter International Inc. fell$. 05 or. 1 percent, to $70.50. Johnson& Johnson fell$. 38 or. 4 percent, to $87.26.

• Midday Glance: Medical Devices companies Wednesday, 15 May 2013 | 1:26 PM ET

  Allergan rose$. 11 or. 1 percent, to $103.89. Baxter International Inc. rose$. 02 or percent, to $70.51. Boston Scientific Corp. rose$. 30 or 3.4 percent, to $9.00.

• Early Glance: Medical Devices companies Wednesday, 15 May 2013 | 10:24 AM ET

  Allergan fell$. 56 or. 5 percent, to $103.22. Baxter International Inc. fell$. 03 or percent, to $70.46. Boston Scientific Corp. rose$. 20 or 2.3 percent, to $8.90.

• Midday Glance: Medical Devices companies Tuesday, 14 May 2013 | 2:11 PM ET

  Baxter International Inc. rose$. 39 or. 6 percent, to $70.85. Boston Scientific Corp. fell$. 02 or. 2 percent, to $8.63. Johnson& Johnson rose$. 84 or 1.0 percent, to $86.69.

• Early Glance: Medical Devices companies Tuesday, 14 May 2013 | 10:37 AM ET

  Allergan fell$. 36 or. 3 percent, to $103.50. Baxter International Inc. rose$. 33 or. 5 percent, to $70.79. Boston Scientific Corp. rose$. 01 or. 1 percent, to $8.66.

• Midday Glance: Medical Devices companies Monday, 13 May 2013 | 1:18 PM ET

  Allergan fell$. 18 or. 2 percent, to $104.00. Baxter International Inc. fell$. 03 or percent, to $70.74. Boston Scientific Corp. rose$. 29 or 3.4 percent, to $8.74.

• Early Glance: Medical Devices companies Monday, 13 May 2013 | 10:22 AM ET

  Allergan fell$. 37 or. 4 percent, to $103.82. Baxter International Inc. fell$. 34 or. 5 percent, to $70.42. Medtronic fell$. 02 or percent, to $49.15.

• After-Hours Buzz: REGN, QCOM, ZNGA, AKAM & More Wednesday, 24 Apr 2013 | 5:28 PM ET

  

  Check out which companies are making headlines after the bell Wednesday:

• Apple's Roller-Coaster Ride to Set Market Tone Tuesday, 23 Apr 2013 | 8:38 PM ET

  

  Apple briefly got some of its shine back, after it delivered a package of capital programs that shareholders have been clamoring for.

• A Make-or-Break Week Ahead for the Stock Market Saturday, 20 Apr 2013 | 12:30 AM ET

  

  It's make-or-break time for the first-quarter earnings season, and it comes just as the stock market is showing signs of strain.

• UPDATE 3-J&J tops estimates as prescription, OTC drugs shine Tuesday, 16 Apr 2013 | 12:15 AM ET

  April 16- Johnson& Johnson beat Wall Street's quarterly profit estimates on sharply lower taxes, strong sales of prescription drugs and a revival of over-the-counter medicines that had been recalled over quality control problems.

• Bulls See More Upside in Stryker Tuesday, 12 Feb 2013 | 6:29 AM ET

  

  Stryker pulled back after running hard in January, and now the bulls are looking for more upside.

• Are These Stocks Overbought? Friday, 25 Jan 2013 | 9:41 AM ET

  

  More than 93 percent of the S&P 500 are trading above their moving 50-day moving average.